Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
17-3
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
17-3
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #75841
advertisement
Ghahari E
10
Showing records 1 to 10 |
Display all abstracts from
Ghahari E
66619
Biometric Changes After Trabeculectomy with Contact and Non-contact Biometry
Alvani A
Optometry and Vision Science
2016; 93: 136-140
66508
The Ocular Hypotensive Efficacy of Topical Fasudil, a Rho-Associated Protein Kinase Inhibitor, in Patients With End-Stage Glaucoma
Pakravan M
American Journal of Therapeutics
2017; 24: e676-e680
66619
Biometric Changes After Trabeculectomy with Contact and Non-contact Biometry
Pakravan M
Optometry and Vision Science
2016; 93: 136-140
66508
The Ocular Hypotensive Efficacy of Topical Fasudil, a Rho-Associated Protein Kinase Inhibitor, in Patients With End-Stage Glaucoma
Beni AN; Ghahari E
American Journal of Therapeutics
2017; 24: e676-e680
66619
Biometric Changes After Trabeculectomy with Contact and Non-contact Biometry
Esfandiari H; Yaseri M
Optometry and Vision Science
2016; 93: 136-140
66508
The Ocular Hypotensive Efficacy of Topical Fasudil, a Rho-Associated Protein Kinase Inhibitor, in Patients With End-Stage Glaucoma
Varshochian R
American Journal of Therapeutics
2017; 24: e676-e680
66619
Biometric Changes After Trabeculectomy with Contact and Non-contact Biometry
Yazdani S
Optometry and Vision Science
2016; 93: 136-140
66508
The Ocular Hypotensive Efficacy of Topical Fasudil, a Rho-Associated Protein Kinase Inhibitor, in Patients With End-Stage Glaucoma
Yazdani S; Esfandiari H
American Journal of Therapeutics
2017; 24: e676-e680
66619
Biometric Changes After Trabeculectomy with Contact and Non-contact Biometry
Ghahari E
Optometry and Vision Science
2016; 93: 136-140
66508
The Ocular Hypotensive Efficacy of Topical Fasudil, a Rho-Associated Protein Kinase Inhibitor, in Patients With End-Stage Glaucoma
Ahmadieh H
American Journal of Therapeutics
2017; 24: e676-e680
Issue
17-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept